$9.90 0.43 (+4.49%)
2/10/2012 4:00 PM

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN)

CAPS Rating: 2 out of 5

A biopharmaceutical company focuses on the discovery, development and commercialization of innovative treatments for infectious diseases

Featured Broker Partners


Advertisement